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Abstract
The repair of peripheral nerve traumatic lesions still represents a major cause of perma-
nent motor and sensory impairment. In case of substance loss, a nerve guide should be 
used to bridge the proximal with the distal stump of the severed nerve. The effectiveness 
of hollow nerve guides is limited by the delay of axonal growth due to the absence of a 
regeneration substrate inside the conduit. To fasten up nerve regeneration, nerve guides 
should thus be enriched by a luminal filler. In this study, we investigated, in a 12-mm rat 
sciatic nerve defect experimental model, the effectiveness of chitosan-based conduits of 
different acetylation filled either with a hyaluronic acid gel (NVR gel) or with a magnetic 
fibrin hydrogel, in comparison with traditional autografts. Results showed that all types 
of artificial nerve conduits led to functional recovery not significantly different from auto-
grafts. By contrast, morphological and morphometrical analyses showed that the best 
results among nerve guides were found in medium degree of acetylation (DAII: ∼5%) 
chitosan conduits enriched with the NVR gel.
Keywords: peripheral nerve injury, chitosan guidance conduit, conduit acetylation, 
hyaluronic acid gel, magnetic fibrin hydrogel
1. Introduction
Chitosan is a biopolymer derived from chitin that can be extracted in large quantities 
from the shells of the crustaceans. Among the different applications, the use of chitosan 
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as a scaffold for neural repair is receiving growing interest from the scientific commu-
nity and, in particular, many experimental studies have shown that chitosan-based con-
duits provide an effective scaffold for the reconstruction of peripheral nerve defects [1]. 
Recently, chitosan hollow nerve guides have been approved for clinical use (Reaxon® 
Nerve Guide) [2].
In spite of these positive results, the early growth of axons along hollow nerve guides is 
delayed since the conduit’s lumen should first be colonized by connective tissue and Schwann 
cells migrating from the distal nerve stump [3, 4]. To prevent this occurrence, a luminal filler 
must be used for providing a substrate for early nerve fiber regeneration [5–7]. A number of 
different materials have been investigated as luminal fillers for nerve guides, including bio-
logical or artificial substrates [8–11].
The aim of the present study was to investigate rat sciatic nerve reconstruction with chitosan 
conduits filled up with two types of substrates which might potentially improve axon regen-
eration, namely (i) NVR gel and (ii) magnetic fibrin hydrogel.
NVR gel is a gel based on hyaluronic acid (HA), a non-immunogenic biopolymer that has 
been proposed for various tissue engineering applications [12, 13]. HA is a glycosamino-
glycan composed of disaccharide D-glucuronic acid and N-acetyl-D-glucosamine produced 
by hyaluronan synthases, a membrane-bound enzyme. It is a component of ECM where it 
modulates cell adhesion, migration, and neuronal sprouting, and it controls tissue homeo-
stasis and absorbs mechanical shock. HA action is related to its molecular weight; a long 
polymer (>500 kDA) is generally known as high molecular weight HA (HMW HA) and is 
found predominantly in the brain where it has a structural role and takes part in various 
biological process like silences inflammation, angiogenesis and neural differentiation [14]. In 
the peripheral nerves, HA is one of the prominent components of the Bunger band formed 
during Wallerian degeneration, and the ablation of HA receptors can reduce cell adhesion 
and migration [15]. Several studies showed that HA has a positive effects on peripheral nerve 
regeneration [16, 17].
Fibrin hydrogels are natural polymers made by mixing two blood coagulation components, 
fibrinogen and thrombin, which form a clot upon mixing.
In previous studies, it was demonstrated that appropriate conjugation of thrombin to iron 
oxide (γ-Fe2O3) magnetic nanoparticles preserved the thrombin-clotting activity, stabilized 
the thrombin against its major inhibitor, antithrombin III, and improved its storage stability 
[18, 19]. Moreover, these thrombin-conjugated γ-Fe2O3 nanoparticles were used to fabricate novel magnetic fibrin hydrogel scaffolds [20].
2. Materials and methods
2.1. Chitosan tube preparation
Chitosan conduits were provided by Medovent GmbH (Mainz, Germany). They were produced 
under ISO 13485 conditions from chitin tubes made by extrusion process. Distinctive washing 
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and hydrolysis steps were then carried out to adjust the required low, medium, and high degree 
of acetylation (DA): (1) DAI tubes (low DA, ∼2%); (2) DAII tubes (medium DA, ∼5%); and (3) 
DAIII tubes (high DA, ∼20%). Tubes were finally cut and sterilized by electron beam.
2.2. Preparation of NVR gel
NVR gel was prepared by mixing high molecular weight hyaluronic acid (3×106 Da, BTG 
Polymers, Kiryat Malachi, Israel) and laminin (Sigma, Rehovot, Israel). The NVR gel was then 
diluted with nutrient medium (composed of 86% Dulbecco’s modified Eagle medium-nutri-
ent mixture F-12), 10% heat-denatured fetal calf serum (FCS), 6 g/L D-glucose, 2 nM gluta-
mine, 25 μg/mL gentamycin, and 50 ng/mL IGF-I, all purchased from Biological Industries, 
Israel, to a final concentration of 0.5%. NVR gel was then injected into the chitosan tubes 
immediately before surgical implantation.
2.3. Preparation of the magnetic fibrin hydrogel
Magnetic fibrin hydrogel was prepared by mixing 30 μL of bovine fibrinogen (from stock 
solution of 100 mg/mL, in PBS without Ca2+ and Mg2+), 460 μL of a culture medium, and 10 μL 
of a CaCl2 aqueous solution (from stock solution of 25 mM). To achieve coagulation, thrombin was conjugated to iron oxide nanoparticles [19–21] and added to the gel (50 μL from a stock 
solution of 100 μg/mL). The final liquid mixture was then injected into the chitosan conduits 
immediately before surgical implantation.
2.4. Experimental design and surgical technique
All animal experiments were approved by the Institutional Animal Care and Usage 
Committee (IACUC) and adhered strictly to the Animal Care Guidelines of University 
Tel Aviv Sourasky Medical Center (number of approval for animal testing 9-3-12). Female 
Wistar rats were brought to the vivarium 2 weeks prior to the surgery and housed two 
per cage with a 12-h light/dark cycle, with free access to food and water. The study was 
conducted on 45 female Wistar rats (weight 200–250 g), using an experimental model for 
producing a complete peripheral nerve injury with massive nerve defect that has been 
recently described [22].
General anesthesia was induced with intraperitoneal injection of xylazine (15 mg/kg) and 
ketamine (50 mg/kg). Surgical procedures were performed using a high magnification micro-
scope. The left sciatic nerve was exposed and separated from biceps femoris and semimem-
branosus muscles beginning from the area of branches to the glutei and hamstring muscles 
and distally to the trifurcation into peroneal, tibial, and sural nerves. The sciatic nerve was 
completely transected at the third femur level using microsurgical scissors and a 6-mm nerve 
segment was removed. A 14-mm chitosan hollow conduit of different degrees of acetylation 
(DAI ~2%; DAII ~5%; DAIII ~20%) filled with 0.5% NVR gel was placed between the proximal 
and the distal parts of the transected nerve for reconstruction, enabling the nerve to enter the 
conduit 1 mm on each side, while providing a 12-mm gap between the proximal and distal 
ends. Two 9–0 non-absorbable sutures were used to anchor the conduit to the epineurium at 
the proximal and distal nerve stumps (Figure 1).
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Only one experimental group was used for testing magnetic fibrin hydrogel injected inside 
DAI tubes.
Autologous nerve graft reconstruction was adopted as control. The left sciatic nerve was 
exposed as described above and then sharply incised with microscissors at the femur level 
below the superior gluteal nerve and above the division of the sciatic nerve to the tibial 
nerve and the peroneal nerve. A nerve segment of 12 mm was harvested, turned upside 
down, and immediately replaced to bridge the nerve gap using 2–3 non-absorbable 10-0 
sutures for each stump. Coaptation of nerve fascicles was carried out to preserve all the 
fascicles within the epineural sac. The muscular, subcutaneous and skin layers were 
closed.
Experimental groups can be then summarized as follows: DAI tubes filled with NVR gel 
(n = 10); DAII tubes filled with NVR gel (n = 10); DAIII tubes filled with NVR gel (n = 10); DAI 
tubes filled with magnetic fibrin hydrogel (n = 10); and autologous nerve grafts (n = 5).
2.5. Functional analysis and electrophysiological evaluation
Preoperative evaluation and postoperative follow-up were performed and consisted of 
motor assessment of the sciatic nerve utilizing sciatic functional index (SFI) (data not shown) 
and somatosensory evoked potentials (SSEP). SFI and SSEP were tested preoperatively and 
retested at 90 and 120 days postoperatively.
All assessments were carried out in a blinded manner without disclosure of rat’s affiliation to 
the evaluating team.
SSEP were recorded in both the operated and intact hind limbs using a Dantec™ KEYPONT® 
PORTABLE. Conductivity of rat sciatic nerve and spinal cord was studied by stimulation of 
the sciatic nerve at the level of the tarsal joint with simultaneous recording from the skull 
over the somatosensory cortex in anesthetized rats. Two subcutaneous needle electrodes 
were inserted under the skin of the scalp with the active electrode over the somatosensory 
cortex along the midline and reference electrode between the eyes. The ground electrode 
was placed subcutaneously on the dorsal neck. The sciatic nerve was stimulated by a set 
of two polarized electrodes placed on the lateral aspect of the tarsal joint. Three hundred 
Figure 1. In vivo image of sciatic nerve reconstruction using chitosan-based scaffold immediately after its implantation.
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stimulation pulses of 0.2 ms in duration were generated at a rate of 3 Hz. The stimulus inten-
sity was set on 2–5 mA, and a slight twitching of the limb was noted in all rats. The appear-
ance of an evoked potential in at least two consecutive tests as a response to a stimulus was 
considered positive.
2.6. Morphological and stereological analysis
Nerve samples were collected 120 days after surgery. The complete conduits were harvested 
together with parts of proximal and distal nerves, and the whole specimens were fixed for 4–6 h 
at 4°C in 2.5% glutaraldehyde prepared in 0.1 M phosphate buffer (pH 7.4). A postfixation was 
then performed using 2% osmium tetroxide for 2 h, followed by dehydration in ethanol from 
30 to 100%. After two washings with propylene oxide of 7 min each, samples were left for an 
hour in a mixture of propylene oxide and Glauerts’ mixture of resins (50% Araldite HY964, 50% 
Araldite M, and 0.5% dibutylphthalate) mixed in equal parts. Then, samples were immersed 
in Glauerts’ mixture of resins and left overnight. A second immersion with Glauerts’ mixture 
of resin was then performed, leaving samples at 37°C for 1 h. Samples were then immersed 
twice for 30 min in resin with the addition of 2% of accelerator 964 and finally left in resin 
for three days at 60°C. Resin-embedded nerves were then processed for stereological analysis: 
transverse sciatic nerve sections were prepared starting from the distal part of the samples. For 
optical analysis, semi-thin sections (2.5 μm of thickness) were prepared using Ultracut UCT 
ultramicrotome (Leica Microsystems, Wetzlar, Germany) and stained with 1% toluidine blue.
The stereological analysis [23] was performed on semi-thin transverse nerve section stained 
with toluidine blue using DFC320 digital camera on DM4000B microscope. A random 
selected semi-thin section was analyzed for each sample with the help of specific image soft-
ware (IM50 image manager system, Leica Microsystems). The total cross-sectional area of 
the nerve was measured. Then, 12–16 fields of the section were randomly selected following 
a systematic random protocol and proceeded as described previously [24] to measure the 
following parameters: total number of myelinated fibers, axon diameter and fiber diameter, 
myelin thickness, and g-ratio. Finally, the correlation between g-ratio and axon diameter of 
individual fibers was carried out as scatter plot graphs.
2.7. Statistical analysis
Functional and electrophysiological analyses were done using MATLAB software (v.2008b, The 
MathWorks, Inc.). Non-parametric statistics were used in this study. Hence, all figures are 
presented with Median ± MAD. Significance levels were calculated using a Mann-Whitney U 
test and a Wilcoxon signed-rank test. SSEP responses were analyzed as categorical parameters 
using χ2 test.
For stereological analysis, one-way ANOVA followed by Bonferroni post hoc test was performed 
using SPSS Statistic Program. The GraphPad software was used to obtain the regression line 
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in scatter plot and to test whether slopes are significantly different. Results are reported as a 
mean ± standard deviation.
3. Results
3.1. Functional analysis and electrophysiological evaluation
Due to autotomy which often occurs in the operated hind limb [25], the number of rats avail-
able for meaningful SFI testing was not sufficient for reliable statistics (data not shown). The 
group of low acetylation conduit (DAI) filled with NVR gel had the lowest number of autoto-
mies (4 out of 10), while the group of low acetylation (DAI) conduit filled with magnetic fibrin 
hydrogel had the highest number of autotomies (8 out of 10 rats).
For the electrophysiological evaluation, the SSEP peak-to-peak (P2P) amplitude was calcu-
lated. Two consecutive electrophysiological recordings were performed on 38 and 39 rats 
during 90 and 120 days, respectively. In order to evaluate P2P amplitude in the operated 
and intact limbs, we calculated the results from each limb separately. No significant differ-
ences were found between limbs (data not shown). Rats with P2P measurement in only one 
of the limbs were ignored in calculations from limb comparison. Regarding the operated 
limb, no significant differences were observed between all groups after both 90 and 120 days 
(Figure 2).
The P2P values of the intact limb were subtracted from the values of the operated limb in 
order to evaluate the effectiveness of the various conduits and fillers. A value closer to “0” 
indicates similar activity in both intact and operated limbs, while a major shift is an indicator 
of neurological dysfunction. As can be seen in Figure 3, all groups evolved with a value close 
to “0,” and no significant difference among the various acetylation conduits and fillers was 
detected.
3.2. Morphological and stereological analysis
During harvesting (120 days postoperation), a macroscopic observation was performed in 
order to evaluate the degradation conditions of the conduit and the presence of nerve filaments 
inside the conduit reconnecting the two nerve stumps. This qualitative analysis showed that 
2 rats out of 9 of DAI-NVR gel group and 6 rats out of 10 of DAIII-NVR gel group showed con-
duits with sign of degradation. Moreover, 5 rats out of 7 of DAI-magnetic fibrin clot group, 
7 rats out of 9 of DAI-NVR gel group, 8 rats out of 10 of DAII-NVR gel group, and 8 rats out of 
10 of DAIII-NVR gel group showed macroscopically signs of regeneration. This macroscopic 
observation was then confirmed after histological analysis.
The morphological evaluation was carried out on regenerated nerves immediately down-
stream to the conduit, 120 days after nerve repair. Representative high-resolution light 
microscopy images of transverse semi-thin sections of regenerated sciatic nerves of all 
experimental groups are shown in Figure 4. A good regeneration was observed in most of 
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the samples for each experimental group: autologous nerve graft (Figure 4A); DAI-magnetic 
fibrin clot (Figure 4B); DAI-NVR gel (Figure 4C); DAII-NVR gel (Figure 4D); DAIII-NVR 
gel (Figure 4E).
Semi-thin sections were also used to perform stereological analysis for the evaluation of the 
number of myelinated fibers, the axon and fiber size, and the myelin thickness.
Figure 3. Evaluation of the effectiveness of various acetylation conduits and fillers. The P2P values of the intact limb were 
subtracted from the values of the operated limb.
Figure 2. Somatosensory evoked potentials (SSEP) peak-to-peak (P2P) amplitude in operated limbs in various treatments 
during 90 and 120 days postoperatively. Values are presented with median ± MAD.
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Figure 5. The graphs show the results of stereological analysis on semi-thin sections of the distal part of regenerated 
nerves. The number of myelinated fibers (A), axon diameter (B), the myelin thickness (C), the fiber diameter (D), and 
the g-ratio (E) were evaluated 120 days after surgery. All data are presented as means±SD; statistical analysis: one-way 
ANOVA with post hoc Bonferroni test.
Figure 4. Representative semi-thin sections of the distal part of a sciatic nerve repaired with (A) autologous nerve graft; 
(B) low acetylation (DAI) conduit filled with magnetic fibrin clot; (C) low acetylation conduit (DAI) filled with NVR gel; 
(D) medium acetylation (DAII) conduit filled with NVR gel; (E) high acetylation (DAIII) conduit filled with NVR gel. A 
good regeneration after nerve repair is detectable in all groups. Scale bar: 20 μm.
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As we can observe from the graph (Figure 5A), the total number of myelinated fibers in DAI 
magnetic fibrin clot group is about two-thirds smaller than the autograft group (p = 0.05). 
Moreover, the number of myelinated fibers in all NVR gel groups is similar to each other 
and about one-third reduced compared to the autograft group. Although the differences are 
evident, they can only be interpreted as a statistical trend of p < 0.1 due to the high standard 
deviation (that is probably due to the high variability in the regeneration success observed for 
all-gel-filled conduits).
Axon and fiber diameter, myelin thickness, and g-ratio are not statistically different among 
all groups (Figure 5B–E).
Scatter plot graphs in Figure 6 represent the correlation between g-ratio and axon diameter of 
individual fibers. All groups are compared to the autograft, considered as control. Data show 
that in DAI-magnetic fibrin clot, DAI-NVR gel, and DAIII-NVR gel group, the slope of the 
regression line is significantly different from the autograft (Figure 6A, B, D). Contrary, there is 
no difference between autograft and DAII-NVR gel group (Figure 6C) since the slope of the 
two regression lines is not significant different.
Figure 6. Scatter plot graphs display g-ratio (y-axis) in relation to axon diameter (x-axis) of individual fiber. More than 
250 myelinated axons were considered for each group. All the experimental groups are compared to autograft. The 
slope of linear regression for (A) DAI conduit filled with magnetic fibrin clot, (B) DAI conduit filled with NVR gel, 
and (D) DAIII conduit filled with NVR gel is significantly different from the autograft. On the contrary, there are no 
significant differences between autograft and the group DAII conduit filled with NVR gel (C). The statistical analysis 
was performed using Prism Program, comparing the slope of the linear regression.




Peripheral nerves are very often subjected to traumatic lesions both because of accidents 
(e.g., at work, on the road, and at home) and also because of iatrogenic damage (e.g., onco-
logic surgical excisions) [26, 27]. When the lesion causes substance loss, the two nerve stumps 
must be connected by a nerve guide in order to allow regenerating axons to bridge the gap 
[28, 29]. The nerve guide can be represented by an autologous nerve segment (traditional 
autograft), e.g., from the sural nerve or by a non-nervous conduit [5, 30]. Along the last years, 
an increasing number of papers describing innovative bio-artificial nerve guides has been 
published [7]. In general, nerve guides are composed of two main components: a tubular 
scaffold which can be sutured (or glued) to the nerve stumps and a luminal filler which pro-
vides the substrate for cell migration and axon regeneration inside the conduit.
In this study, we selected the chitosan as the biomaterial of choice for fashioning the nerve 
conduit based on the previous in vitro and in vivo experimental evidences. In vitro, it has 
been shown that chitosan membranes are a suitable substrate for survival and orientation of 
Schwann cell growth as well as survival and differentiation of neuronal cells [31, 32]. In vivo, 
studies showed that chitosan tubes can efficiently bridge peripheral nerve defects [33–36].
On the other hand, two types of luminal filler have been investigated in this study: (i) NVR 
gel and (ii) magnetic fibrin hydrogel.
The selection of NVR gel as a potentially bioactive luminal filler has been based on a number of 
studies that have proposed his employment for various tissue engineering applications [12, 13]. In 
peripheral nerves, HA has positive effects on peripheral nerve regeneration modulating glial cell 
adhesion and migration and neuronal sprouting [15–17]. Yet, topical application of HA is able to 
reduce the scar formation and create a more favorable environment for nerve regeneration [37, 38].
The results of this study, which compared HA gel enrichment of three different types of 
chitosan conduits with traditional autografts, showed no significant inter-group differences 
in the electrophysiological functional outcome and with respect to all histomorphometrical 
predictors of axon regeneration. By contrast, g-ratio and axon diameter correlation plots (a 
strong predictor of nerve fiber maturation) showed significant differences between auto-
graft and all groups of conduits except for NVR gel-enriched medium degree of acetylation 
(DAII). The better performance of DAII (w5%) conduits is in line with a previous report 
which compared chitosan hollow conduits with different degrees of acetylation in the rat 
sciatic nerve model [35] and might be explained with the need of a medium-degree degrada-
tion time (several months). In fact, the degree of acetylation is directly related to the degrada-
tion velocity of the biomaterial, resulting in too slow degradation (more than 1 year) under 
low acetylation conditions and too fast degradation (several weeks) under high acetylation 
conditions [35].
As regards the choice of magnetic fibrin hydrogel, the second potentially bioactive luminal 
filler investigated in this study, this has been based on its previous successful use for tis-
sue engineering applications in various tissues and organs [39–43]. Fibrin hydrogels combine 
some important advantages such as inherent flexibility, soft, high seeding efficiency, and they 
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cast easily into three-dimensional shapes, can be injected directly into the site of an injury, and 
contain cell-binding sites which enhance cell adhesion [44, 45].
In this study, thrombin-conjugated γ-Fe2O3 nanoparticles were used to fabricate the magnetic fibrin hydrogel in order to enrich low acetylation (DAI) chitosan conduits. The selection of 
DAI conduits instead of DAII conduits, which showed a better performance in other experi-
ments (35), was due to the fact that, when these experiments started, full data on the compari-
son among different acetylation chitosan scaffolds were not available yet.
Results of the electrophysiological assessment showed that no significant difference in func-
tional recovery can be detected between magnetic fibrin hydrogel-enriched DAI conduits, 
NVR gel-enriched DAI conduits and traditional autografts. By contrast, as regards morpho-
metrical analysis, magnetic fibrin hydrogel-enriched DAI conduits showed significantly less 
fibers than autograft.
5. Conclusion
Altogether, the results of our study showed that the enrichment of chitosan tubes with both 
NVR gel and magnetic fibrin hydrogel for the repair of 12 mm long rat sciatic nerve gaps 
leads to a degree of functional recovery (measured by electrophysiology) not significantly 
different from traditional autograft. The functional results were not completely matched by 
the histomorphometric investigation of nerve fibers that showed that best results were found 
in medium degree (w5%) of acetylation chitosan conduits enriched with the NVR gel. This 
occurrence, which is not surprising since several studies previously showed that morphologi-
cal and functional predictors of nerve regeneration are often unrelated [46], must be taken 
into consideration when translating experimental results to the clinics.
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